Document 0080
 DOCN  M9620080
 TI    Glaucoma: early detection and therapy for prevention of vision loss [see
       comments]
 DT    9602
 AU    Rosenberg LF; Northwestern University Medical School, Chicago, Illinois,
       USA.
 SO    Am Fam Physician. 1995 Dec;52(8):2289-98, 2303-4. Unique Identifier :
       AIDSLINE MED/96094655
 CM    Comment in: Am Fam Physician 1995 Dec;52(8):2167, 2170, 2173
 AB    Glaucoma is the second most common cause of permanent blindness in the
       United States and the most common cause of blindness among blacks. It is
       characterized by optic atrophy and vision loss, resulting from
       intraocular pressure that is too high to allow normal function of the
       optic nerve. Examination of the optic nerve and assessment of individual
       risk factors aids in the identification of patients who are at risk for
       glaucoma. Although glaucoma is a chronic disease, ocular complications
       can be prevented and sight may be preserved if the disease is detected
       early. A combination of antiglaucoma medications, laser treatment and
       filtration surgery is used to maintain intraocular pressure at a level
       sufficient to halt progression of optic nerve injury and prevent further
       vision loss.
 DE    Adrenergic beta-Agonists/THERAPEUTIC USE  Filtering Surgery
       Glaucoma/COMPLICATIONS/*DIAGNOSIS/EPIDEMIOLOGY/*THERAPY  Glaucoma,
       Angle-Closure/COMPLICATIONS/THERAPY  Glaucoma,
       Open-Angle/COMPLICATIONS/THERAPY  Human  Miotics/THERAPEUTIC USE  Risk
       Factors  Support, Non-U.S. Gov't  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).